Kennedy Capital Management, Inc. Verona Pharma PLC Transaction History
Kennedy Capital Management, Inc.
- $4.23 Billion
- Q4 2024
A detailed history of Kennedy Capital Management, Inc. transactions in Verona Pharma PLC stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 346,103 shares of VRNA stock, worth $21.7 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
346,103
Previous 358,447
3.44%
Holding current value
$21.7 Million
Previous $10.3 Million
55.87%
% of portfolio
0.38%
Previous 0.24%
Shares
7 transactions
Others Institutions Holding VRNA
# of Institutions
226Shares Held
67.7MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$401 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$350 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$212 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$196 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$196 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.82B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...